Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Institute of Hematology & Blood Diseases Hospital, China
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
Medical College of Wisconsin
Ohio State University Comprehensive Cancer Center
Goethe University
Thomas Jefferson University
H. Lee Moffitt Cancer Center and Research Institute
Astellas Pharma Inc
Case Comprehensive Cancer Center
French Innovative Leukemia Organisation
Therapeutic Advances in Childhood Leukemia Consortium
National Institutes of Health Clinical Center (CC)
Ohio State University Comprehensive Cancer Center
Center for International Blood and Marrow Transplant Research
Massachusetts General Hospital
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
German CLL Study Group
Memorial Sloan Kettering Cancer Center
Cedars-Sinai Medical Center
Masonic Cancer Center, University of Minnesota
Stanford University
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Arog Pharmaceuticals, Inc.
St. Petersburg State Pavlov Medical University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Alabama at Birmingham
Arog Pharmaceuticals, Inc.
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
IRCCS San Raffaele
National Institutes of Health Clinical Center (CC)
Dartmouth-Hitchcock Medical Center
M.D. Anderson Cancer Center
Northside Hospital, Inc.
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Northside Hospital, Inc.
Goethe University
TCR2 Therapeutics
Gruppo Italiano Trapianto di Midollo Osseo
Precision BioSciences, Inc.
Weill Medical College of Cornell University
Medical College of Wisconsin